OptioRx
Optio Rx, a US-licensed provider of specialty compounding pharmacies and home infusion services.
Founded
2018Optio Rx, a US-licensed provider of specialty compounding pharmacies and home infusion services.
Founded with a mission to enhance patient care through specialized pharmaceutical services, Optio Rx operates as a premier national provider of specialty compounding pharmacies and home infusion services. The company focuses on delivering customized medications for both human and veterinary patients, addressing unique therapeutic needs that standard medications cannot meet. Licensed across the United States, Optio Rx offers a range of specialized therapies, including Bioidentical Hormone Replacement Therapy (BHRT) and Low Dose Naltrexone, ensuring nationwide convenience and speed to therapy.
Optio Rx has garnered attention for its commitment to quality and patient care, earning accreditations that underscore its reliability and excellence in the pharmaceutical industry. The company collaborates with a network of healthcare providers to ensure seamless service delivery. Notable investors and affiliated individuals have supported Optio Rx's growth, contributing to its reputation as a trusted partner for both patients and healthcare providers. Through its innovative approach and dedicated service, Optio Rx has significantly impacted the specialty pharmacy sector, improving health outcomes for diverse patient populations.
Companies similar to OptioRx include Option Care Health, OptimizeRx, Local Infusion and Strive Pharmacy.
OptioRx was founded in 2018.
OptioRx's headquarters is located in Oak Brook, IL, US.
OptioRx's most recent funding round was for $27.3M (USD) in July 2018.
As of Jul 23, 2018, OptioRx has disclosed funding of $27.3M (USD). Undisclosed round amounts are excluded.
OptioRx has 350 employees as of Feb 5, 2024.
strivepharmacy.com
